Written question asked by Martyn Day (Scottish National Party) on Friday, 17 November 2023, in the House of Commons. It was due for an answer on Tuesday, 21 November 2023. It was answered by Andrew Stephenson (Conservative) on Wednesday, 22 November 2023 on behalf of the Department of Health and Social Care.
Alzheimer's Disease: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, whether his Department has had recent discussions with NHS Scotland on ensuring that newly-licensed Alzheimer's treatments are made available to patients as soon as possible in all regions of the UK.
- Answer
-
The Department has liaised with colleagues in the Scottish Government to discuss preparations for the introduction and potential adoption of new medicines for Alzheimer’s disease, should they receive regulatory approval.
Secondary information
- Type
- Written question
- Reference
- 2411
- Session
- 2023-24
- Subjects
- Alzheimer's disease Drugs NHS Scotland
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-11-22 17:04:02 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/2411
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/2411
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/2411